Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Abdalla FB et al. |
Estrogen receptor, progesterone receptor, and nuclear size features in female breast cancer in Libya: correlation with clinical features and survival.
|
|
2 |
Al-Maghrabi J et al. |
Expression of cell cycle regulators P21 and P27 as predictors of disease outcome in colorectal carcinoma.
|
|
3 |
Al-Maghrabi J et al. |
Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma.
|
|
4 |
Arjamaa O, Minn H. |
Resistance, not tachyphylaxis or tolerance.
|
|
5 |
Auranen A et al. |
Fibroosia suoliliepeessä - voisiko olla desmoidi?
|
|
6 |
Avoranta ST et al. |
Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence.
|
|
7 |
Costa S et al. |
Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: An analysis of 166 cases.
|
|
8 |
El Gehani K et al. |
Over-expression of HER-2 is associated with the stage in carcinoma of the urinary bladder.
|
|
9 |
Elzagheid A et al. |
Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma.
|
|
10 |
Ermiah E et al. |
Prognostic significance of DNA image cytometry in Libyan breast cancer.
|
|
11 |
Ermiah E et al. |
Diagnosis delay in Libyan female breast cancer.
|
|
12 |
Ermiah E et al. |
Prognostic value of proliferation markers:immunohistochemical Ki-67 expression and cytometric S-phase fraction of women with breast cancer in Libya.
|
|
13 |
Eskola O et al. |
Tracer level electrophilic synthesis and pharmacokinetics of the hypoxia tracer [18F]EF5.
|
|
14 |
Hervonen P et al. |
Biweekly docetaxel is better tolerated than conventional three-weekly dosing for advanced hormone-refractory prostate cancer.
|
|
15 |
Holmgren O et al. |
Radonin terveyshaitat tiedetään.
|
|
16 |
Huang JX et al. |
Clinicopathological significance of cyclooxygenase-2 and cell cycle-regulatory proteins expression in patients with esophageal squamous cell carcinoma.
|
|
17 |
Jambor I et al. |
Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT.
|
|
18 |
Joensuu H et al. |
Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: Final analysis of the randomized FinXX Trial.
|
|
19 |
Jyrkkiö S et al. |
Tupakointi ja syöpä - mitä hyötyä lopettamisesta?
|
|
20 |
Jyrkkiö S et al. |
Syöpäpotilaan suun hoidon erityispiirteet .
|
|
21 |
Jyrkkiö S et al. |
Special features of oral care in cancer patientents.
|
|
22 |
Kankaanranta L et al. |
Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.
|
|
23 |
Kero K et al. |
Oral mucosa as a reservoir of human papillomavirus: Point prevalence, genotype distribution, and incident infections among males in a 7-year prospective study.
|
|
24 |
Kero K et al. |
Reply from authors re: Guido Barbagli, Salvatore Sansalone, Massimo Lazzeri. Oral mucosa and urethroplasty: It's time to change. Oral mucosa as a reservoir of human papillomavirus: Implications for the use of oral mucosal transplants in
urethroplasty.
|
|
25 |
Klionsky DJ et al. |
Guidelines for the use and interpretation of assays for monitoring autophagy.
|
|
26 |
Komar G et al. |
Noninvasive parametric blood flow imaging of head and neck tumours using [15O]H2O and PET/CT.
|
|
27 |
Korkeila E. |
Biomarkkereista apua peräsuolisyövän ennusteen arviointiin?
|
|
28 |
Korkeila E et al. |
Haiman adenokarsinooma - hoidollinen haaste.
|
|
29 |
Korkeila E et al. |
Main effects and interactions of carbonic anhydrase IX, hypoxiainducible factor-1a, ezrin and glucose transporter-1 in multivariate analysis for disease outcome in rectal cancer.
|
|
30 |
Koskimaa H-M et al. |
Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes.
|
|
31 |
Koskivuo I et al. |
Melanooma.
|
|
32 |
Lin LL et al. |
Radiation dosimetry and biodistribution of the hypoxia tracer 18F-EF5 in oncologic patients.
|
|
33 |
Lindholm P. |
Gist-kasvainten liitännäishoidot.
|
|
34 |
Llombart A et al. |
Immediate administration of zoledronic acid reduces aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer: 12-month analysis of the E-ZO-FAST Trial.
|
|
35 |
Longatto Filho A et al. |
Papillomavirus from the bench to the clinics.
|
|
36 |
Longatto-Filho A et al. |
Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology.
|
|
37 |
Luksch R et al. |
Primary metastatic Ewing's family tumours: result of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation.
|
|
38 |
Minn H. |
Pään ja kaulan alueen syöpä -uhkaako papilloomaviruksen aiheuttama epidemia?
|
|
39 |
Monsonego J et al. |
Risk assessment and cllinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (The FASE Study).
|
|
40 |
Monsonego J et al. |
Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
|
|
41 |
Mosakhani N et al. |
MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF.
|
|
42 |
Mosakhani N et al. |
MicroRNA profiling differentiates colorectal cancer according to KRAS status.
|
|
43 |
Nordberg J et al. |
Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcoma.
|
|
44 |
Nylund C et al. |
Melanoma-associated cancer-testis antigen 16 (CT16) regulates the expression of apoptotic and antiapoptotic genes and promotes cell survival.
|
|
45 |
Paatero I et al. |
Interaction with ErbB4 promotes hypoxia-inducible factor-1a signaling.
|
|
46 |
Rautava J et al. |
HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas.
|
|
47 |
Rautava J et al. |
Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: A six-year follow-up study.
|
|
48 |
Rintala MA et al. |
High-risk human papillomavirus associated with incident cervical intraepithelial neoplasia developing in mothers in the Finnish Family HPV Study cohort.
|
|
49 |
Räty R et al. |
Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patiens with mantle cell lymphoma:. a prospective
study by the Finnish Lymphoma Group.
|
|
50 |
Saarto T et al. |
Effectiveness of a 12-month exercise program on physical performance and quality of life of breast cancer survivors.
|
|
51 |
Saarto T et al. |
Effect of supervised and home exercise training on bone mineral density among breast cancer patients. A 12-month randomised controlled trial.
|
|
52 |
Salminen E et al. |
Radiation dose estimation in computed tomography axaminations using NRPB-SR250 software in aretrospective analysis of a patient population.
|
|
53 |
Salminen E, Viitala H. |
Syöpäpotilaan ravitsemus.
|
|
54 |
Seppälä J et al. |
A dosimetric phantom study of dose accuracy and build-up effects using IMRT and RapidArc in stereotactic irradiation of lung tumours.
|
|
55 |
Seppälä J. |
The Possibilities and Dosimetric Limitations of MLC-Based Intensity-Modulated Radiotherapy Delivery and Optimization Techniques.
|
|
56 |
Shepherd T, Owenius R. |
Gaussian process models of dynamic PET for functional volume definition in radiation oncology.
|
|
57 |
Shepherd T et al. |
Interactive lesion segmentation with shape priors from offline and online learning.
|
|
58 |
Shepherd T et al. |
Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy.
|
|
59 |
Silvoniemi M et al. |
Physicians' self-assessment of cancer pain treatment skills-more training required.
|
|
60 |
Syrjänen K. |
Ihmisen papilloomavirusta (HPV) löytyy keuhkosyövistä. Systemaattinen katsaus ja meta-analyysi.
|
|
61 |
Syrjänen K et al. |
Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competingrisks regression models.
|
|
62 |
Syrjänen K et al. |
Longitudinal outcomes of high-risk human papillomavirus (HPV) infections as competing-risks events following cervical HPV test at baseline visit in the *NIS-LAMS** cohort.
|
|
63 |
Syrjänen K et al. |
Detection of human papillomavirus genotypes in bronchial cancer using sensitive multimetrix assay.
|
|
64 |
Syrjänen K. |
Detection of human papillomavirus in lung cancer: Systematic review and meta-analysis.
|
|
65 |
Tveit K et al. |
Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study.
|
|
66 |
Veikkolainen V et al. |
ErbB4 modulates tubular cell polarity and lumen diameter during kidney development.
|
|
67 |
Ventelä S et al. |
Identification and regulation of a stage-specific stem cell niche enriched by nanog-positive spermatogonial stem cells in the mouse testis.
|
|
68 |
Vihinen P. |
Edistystä ihomelanooman lääkehoidossa.
|
|
69 |
Vihinen P et al. |
Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma.
|
|
70 |
Ålgars A et al. |
Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients.
|
|
71 |
Ålgars A et al. |
Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
|
|
72 |
Ålgars A. |
Factors Affecting Cancer Behavior with Special Reference to Lymphatic Vessels, Macrophages, EGFR, and Pim-1 in Colorectal Cancer.
|